Skip to main content

Cardiovascular Disease

  • Chapter
  • First Online:
Handbook of Clinical Psychology in Medical Settings

Abstract

One American dies approximately every 39 s due to cardiovascular disease and one third of all deaths in the USA are due to cardiovascular disease. According to the World Health Organization, cardiovascular disease is the most frequent cause of death in the world, except in low-income countries where it is the fourth leading cause of death. Despite a 30.6 % drop in the rate of deaths attributable to cardiovascular disease between 1998 and 2008, cardiovascular disease continues to be the leading cause of death in the USA and accounts for 17 % of national health expenditures. It is expected that by 2030, more than 40 % of adults in the USA will have some form of cardiovascular disease and total direct medical costs will triple from US$ 275.5 billion in 2010 to US$ 818.1 billon.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012 update. Circulation. 2012;125(1):e2–220.

    PubMed  Google Scholar 

  2. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States. Circulation. 2011;123:933–44.

    PubMed  Google Scholar 

  3. Eckel RH. Preventive cardiology by lifestyle intervention: opportunity and/or challenge? Presidential address at the 2005 American Heart Association Scientific Sessions. Circulation. 2006;113(22):2657–61.

    PubMed  Google Scholar 

  4. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473–82.

    CAS  PubMed  Google Scholar 

  5. National High Blood Pressure Education Program (NHBPEP). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Washington, DC: U.S. Department of Health and Human Services; 2004.

    Google Scholar 

  6. National Cholesterol Education Program. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Washington, DC: U.S. Department of Health and Human Services; 2001.

    Google Scholar 

  7. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). National diabetes information clearinghouse: Diagnosis of diabetes; 2008. http://diabetes.niddk.nih.gov/dm/pubs/diagnosis/index.aspx. Accessed: 21 Aug 2011.

  8. National Heart Lung and Blood Institute (NHLBI). Coronary heart disease risk factors; 2011. http://www.nhlbi.nih.gov/health/dci/Diseases/hd/hd_risk.html. Accessed: 21 Aug 2011.

  9. Physical Guidelines Committee. Physical activity guidelines committee report. Washington, DC: U.S. Department of Health and Human Services; 2008.

    Google Scholar 

  10. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40:795–6.

    CAS  PubMed  Google Scholar 

  11. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and mortality: a population based study. Hypertension. 2005;45:499–504.

    CAS  PubMed  Google Scholar 

  12. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Blood pressure monitoring: Task force III: Target-organ damage, morbidity, and mortality. Blood Press Monit. 1999;4:303–17.

    CAS  PubMed  Google Scholar 

  13. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378:1219–30.

    PubMed  Google Scholar 

  14. Mead AA, Atkinson GG, Albin DD, et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease-evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet. 2006;19(6):401–19.

    CAS  PubMed  Google Scholar 

  15. Kelley G, Kelley K. Efficacy of aerobic exercise on coronary heart disease risk factors. Prev Cardiol. 2008;11:71–5.

    CAS  PubMed  Google Scholar 

  16. Mueller PJ. Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity. Clin Exp Pharmacol Physiol. 2007;34:377–84.

    CAS  PubMed  Google Scholar 

  17. Joyner MH, Green DJ. Exercise protects the cardiovascular system: effects beyond traditional risk factors. J Physiol. 2007;587(23):5551–8.

    Google Scholar 

  18. Prasad DS, Kabir Z, Dash AK, Das BC. Smoking and cardiovascular health: a review of the epidemiology, pathogenesis, prevention and control of tobacco. Indian J Med Sci. 2009;63:520–33.

    CAS  PubMed  Google Scholar 

  19. Whincup P, Gilg J, Emberson J, et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ. 2004;329:200–5.

    CAS  PubMed Central  PubMed  Google Scholar 

  20. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2003;(4):CD003041.

    PubMed  Google Scholar 

  21. Bagnardi V, Zatonski W, Scotti L, La Vecchia C, Corrao G. Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J Epidemiol Community Health. 2007;62:615–9.

    Google Scholar 

  22. O’Keefe J, Bybee K, Lavie C. Alcohol and cardiovascular health: The razor-sharp double-edged sword. J Am Coll Cardiol. 2007;50:1009–14.

    Google Scholar 

  23. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192–217.

    CAS  PubMed  Google Scholar 

  24. Goldston K, Baillie AJ. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev. 2008;28:288–306.

    PubMed  Google Scholar 

  25. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146,538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–74.

    PubMed  Google Scholar 

  26. Celano CM, Huffman JC. Depression and cardiac disease: a review. Cardiol Rev. 2011;19(3):130.

    PubMed  Google Scholar 

  27. Kent L, Shapiro P. Depression and related psychological factors in heart disease. Harv Rev Psychiatry. 2009;17:377–88.

    PubMed  Google Scholar 

  28. Brown AH, Barton DA, Lambert GW. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs. 2009;23:583–602.

    PubMed  Google Scholar 

  29. Appels A, Kop WJ, Schouten E. The nature of the depressive symptomatology preceding myocardial infarction. Behav Med. 2000;26:86–9.

    CAS  PubMed  Google Scholar 

  30. Martens EJ, Denollet J, Pedersen SS, et al. Relative lack of depressive cognitions in post-myocardial infarction depression. J Affect Disord. 2006;94:231–7.

    PubMed  Google Scholar 

  31. Appels A, Mulder P. Fatigue and heart disease: the association between “vital exhaustion” and past, present, and future coronary heart disease. J Psychosom Res. 1989;33:727–38.

    CAS  PubMed  Google Scholar 

  32. Glassman A, O’Conner CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–9.

    CAS  PubMed  Google Scholar 

  33. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA. 2003;289:3106–16.

    PubMed  Google Scholar 

  34. Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297:367–79.

    PubMed  Google Scholar 

  35. Appels A, Bär F, van der Pol G, et al. Effects of treating exhaustion in angioplasty patients on new cardiac events: results of the randomized Exhaustion Intervention Trial (EXIT). Psychosom Med. 2005;67:217–23.

    PubMed  Google Scholar 

  36. Saab PG, Bang H, Williams RB, et al. The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. J Psychosom Res. 2009;67:45–56.

    PubMed Central  PubMed  Google Scholar 

  37. Blumenthal JA, Sherwood A, Babyak MA, et al. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol. 2012;60:1053–63.

    CAS  PubMed Central  PubMed  Google Scholar 

  38. Blumenthal JA, Babyak MA, O’Connor C, et al. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA. 2012;308(5):465–74.

    CAS  PubMed Central  PubMed  Google Scholar 

  39. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.

    CAS  PubMed  Google Scholar 

  40. Radloff L. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.

    Google Scholar 

  41. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.

    CAS  PubMed Central  PubMed  Google Scholar 

  42. Appels A, Höppener P, Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol. 1987;17:15–24.

    CAS  PubMed  Google Scholar 

  43. Spielberger CD, Gorsuch RL, Lushene RE. The state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press; 1970.

    Google Scholar 

  44. Derogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. 1983;13:595–605.

    CAS  PubMed  Google Scholar 

  45. Spielberger CD. State-trait anger expression inventory. Odessa: Psychological Assessment Resources, Inc.; 1988.

    Google Scholar 

  46. Cook WW, Medley DM. Proposed hostility and pharisaic-virtue scales for the MMPI. J Appl Psychol. 1954;38:414–8.

    Google Scholar 

  47. Berkman LF, Syme SL. Social networks, host resistance, and mortality: A nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109:186–204.

    CAS  PubMed  Google Scholar 

  48. Cohen S, Hoberman HM. Positive events and social supports as buffers of life change stress. J Appl Soc Psychol. 1983;13:99–125.

    Google Scholar 

  49. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.

    CAS  PubMed  Google Scholar 

  50. Karasek R, Brisson C, Kawakami N, Houtman I, Bongers P, Amick B. The Job Content Questionnaire (JCQ): An instrument for internationally comparative assessments of psychosocial job characteristics. J Occup Health Psychol. 1998;3:322–55.

    CAS  PubMed  Google Scholar 

  51. Siegrist J. Adverse health effects of high effort—low reward conditions at work. J Occup Health Psychol. 2006;1:27–41.

    Google Scholar 

  52. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67:89–97.

    PubMed  Google Scholar 

  53. Rector TS, Kubo SH, Cohn JN. Patient’s self-assessment of their cognitive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Fail. 1987;3:198–209.

    Google Scholar 

  54. Lim LL-Y, Valenti LA, Knapp JC, et al. A self-administered quality of life questionnaire after acute myocardial infarction. J Clin Epidemiol. 1993;46:1249–56.

    CAS  PubMed  Google Scholar 

  55. Höfer S, Lim L, Guyatt G, Oldridge N. The MacNew Heart Disease health-related quality of life instrument: a summary. Health Qual Life Outcomes. 2004;2(1):3. http://www.hqlo.com/content/pdf/1477-7525-2-3.pdf. Accessed: 15 Aug 2011.

  56. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident heart disease: A meta-analysis. J Am Coll Cardiol. 2010;56:38–46.

    PubMed  Google Scholar 

  57. Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med. 2010;72:563–9.

    PubMed  Google Scholar 

  58. Alexander F. Emotional factors in essential hypertension: presentation of a tentative hypothesis. Psychosom Med. 1930;1:173–9.

    Google Scholar 

  59. Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings: blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. JAMA. 1959;169:1286–96.

    CAS  Google Scholar 

  60. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Strauss R, Wurm M. Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 8½ years. JAMA. 1975;233:872–7.

    CAS  PubMed  Google Scholar 

  61. Hollis JF, Connett JE, Stevens VJ, Greenlick MR. Stressful life events, Type A behavior, and the prediction of cardiovascular and total mortality over six years. MRFIT Group. J Behav Med. 1990;13:263–80.

    CAS  PubMed  Google Scholar 

  62. Ragland DR, Brand RJ. Type A behavior and mortality from coronary heart disease. N Engl J Med. 1988;318:65–9.

    CAS  PubMed  Google Scholar 

  63. Friedman M, Thoresen CE, Gill JJ, et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J. 1986;112:653–65.

    CAS  PubMed  Google Scholar 

  64. Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic view of prospective evidence. J Am Coll Cardiol. 2009;53:936–46.

    PubMed  Google Scholar 

  65. Uchino BN. Social support & physical health: understanding the health consequences of relationships. New Haven: Yale University Press; 2004.

    Google Scholar 

  66. Barth J, Schneider S, von Känel R. Lack of social support in the etiology and the prognosis of coronary heart disease: A systematic review and meta-analysis. Psychosom Med. 2010;72:229–38.

    PubMed  Google Scholar 

  67. Frasure-Smith N, Lespérance F, Prince RH, et al. Randomised trial of home-based nursing intervention for patients recovering from myocardial infarction. The Lancet. 1997;350:473–9.

    CAS  Google Scholar 

  68. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334:423–419.

    Google Scholar 

  69. Allegra JR, Mostashari F, Rothman J, Milano P, Cochrane DG. Cardiac events in New Jersey after the September 11, 2001, terrorist attack. J Urban Health. 2005;82:358–63.

    PubMed Central  PubMed  Google Scholar 

  70. Kivimäki M, Virtanen M, Elovainio M, Kouvonen A, Väänänen A, Vahtera J. Work stress in the etiology of coronary heart disease: a meta analysis. Scand J Work Environ Health. 2006;32:431–42.

    PubMed  Google Scholar 

  71. Wilbert-Lampen U, Leistner D, Greven S, et al. Cardiovascular events during World Cup soccer. N Engl J Med. 2008;358:475–83.

    CAS  PubMed  Google Scholar 

  72. Gallo LC, Matthews KA. Understanding the association between socioeconomic status and physical health: do negative emotions play a role? Psychol Bull. 2003;129:10–51.

    PubMed  Google Scholar 

  73. Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J. 2007;28:2972–84.

    PubMed  Google Scholar 

  74. Orth-Gomér K, Schneiderman N, Wang HX, Walldin C, Blom M, Jernberg T. Stress reduction prolongs life in women with coronary disease: The Stockholm Women’s Intervention Trial for Coronary Heart Disease (SWITCHD). Circ Cardiovasc Qual Outcomes. 2009;2:25–32.

    PubMed  Google Scholar 

  75. Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svärdsudd K. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary artery disease: Secondary Prevention in Uppsala Primary Health Care Project (SUPRIM). Arch Intern Med. 2011;171:134–40.

    PubMed  Google Scholar 

  76. Pederson SS, Lemos PA, van Vooren PR, et al. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimous-eluting stent implantation: a rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. J Am Coll Cardiol. 2004;44:997–1001.

    Google Scholar 

  77. Martens EJ, Mols F, Burg MM, Denollet J. Type D personality predicts clinical events after myocardial infarction, above and beyond disease severity and depression. J Clin Psychiatry. 2010;71:778–83.

    PubMed  Google Scholar 

  78. Coyne JC, Jaarsma T, Luttik M, van Sonderen E, van Veldhuisen DJ, Sanderman R. Lack of prognostic value of Type D personality for mortality in a large sample of heart failure patients. Psychosom Med. 2011;73:557–62.

    PubMed  Google Scholar 

  79. Grande G, Romppel M, Vesper J, Schubmann R, Glaesmer H, Herrmann-Lingen C. Type D personality and all-cause mortality in cardiac patients—data from a German cohort study. Psychosom Med. 2011;73:548–56.

    PubMed  Google Scholar 

  80. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet. 2004;364:937–52.

    Google Scholar 

  81. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet. 1990;336:129–33.

    CAS  PubMed  Google Scholar 

  82. Pischke CR, Scherwitz L, Weidner G, Ornish D. Long-term effects of lifestyle changes on well-being and cardiac variables among coronary heart disease patients. Health Psychol. 2008;27:584–92.

    PubMed  Google Scholar 

  83. Heller RF, Knapp JC, Valenti LA, Dobson AJ. Secondary prevention after acute myocardial infarction. Am J Cardiol. 1993;72:759–62.

    CAS  PubMed  Google Scholar 

  84. Maes S, De Gucht V, Goud R, Hellemans I, Peek N. Is the MacNew quality of life questionnaire a useful diagnostic and evaluation instrument for cardiac rehabilitation? Eur J Cardiovasc Prev Rehabil. 2008;15:516–20.

    PubMed  Google Scholar 

  85. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667–75.

    CAS  PubMed  Google Scholar 

  86. Supino PG, Borer JS, Franciosa JA, et al. Acceptability and psychometric properties of the Minnesota Living with Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36. J Card Fail. 2009;15:267–77.

    PubMed  Google Scholar 

  87. Carson P, Tam SW, Ghali JK, et al. Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial. J Card Fail. 2009;15:835–42.

    PubMed  Google Scholar 

  88. Walker C, Reamy BV. Diets for cardiovascular disease prevention: what is the evidence? Am Fam Physician. 2009;79:571–8.

    PubMed  Google Scholar 

  89. Hayman LL. Lifestyle change and adherence issues among patients with heart disease. In: Shumaker SA, Ockene JK, Riekert KA, editors. The handbook of health behavior change. 3rd ed. New York: Springer; 2009. pp. 677–92.

    Google Scholar 

  90. Murdaugh CL, Insel K. Problems with adherence in the elderly. In: Shumaker SA, Ockene JK, Riekert KA, editors. The handbook of health behavior change. 3rd ed. New York: Springer; 2009. pp. 499–518.

    Google Scholar 

  91. Dornelas EA. Stress proof the heart: behavioral interventions for cardiac patients. New York: Springer; 2012.

    Google Scholar 

  92. Dornelas EA. Psychotherapy with cardiac patients : behavioral cardiology in practice. Washington, DC: American Psychological Association; 2008.

    Google Scholar 

  93. Hayes SC, Strosahl K, Wilson KG. Acceptance and commitment therapy : the process and practice of mindful change. New York: Guilford Press; 2012.

    Google Scholar 

  94. Cohen S, Underwood L. Gottlieb BH. Social support measurement and intervention : a guide for health and social scientists. New York: Oxford University Press; 2000.

    Google Scholar 

  95. Prochaska JJ, Spring B, Nigg CR. Multiple health behavior change research: an introduction and overview. Prev Med. 2008;46(3):181–8.

    PubMed Central  PubMed  Google Scholar 

  96. Larkin KT. Stress and hypertension: examining the relation between psychological stress and high blood pressure. New Haven: Yale University Press; 2005.

    Google Scholar 

  97. Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease. Circulation. 2005;111(3):369–76.

    PubMed  Google Scholar 

  98. Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update. Circulation. 2007;115(20):2675–82.

    PubMed  Google Scholar 

  99. American Association for Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. 4th ed. Champaign: Human Kinetics Publishers; 2004.

    Google Scholar 

  100. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized trials. Am J Med. 2004;116:682–97.

    PubMed  Google Scholar 

  101. Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of mortality and myocardial infarction among elderly medicare beneficiaries. Circulation. 2010;121:63–70.

    PubMed Central  PubMed  Google Scholar 

  102. Stephens MB. Cardiac rehabilitation. Am Fam Physician. 2009;80(9):955–9. (hand-out 960).

    PubMed  Google Scholar 

  103. Brown TM, Hernandez AF, Bittner V, et al. Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association’s Get With The Guidelines Program. J Am Coll Cardiol. 2009;54(6):515–21.

    PubMed Central  PubMed  Google Scholar 

  104. Whitlock EP, Orleans CT, Pender N, Allan J. Evaluating primary care behavioral counseling interventions. Am J Prev Med. 2002;22(4):267–84.

    PubMed  Google Scholar 

  105. Jackson G, Rosen RC, Kloner RA, Kostis JB. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med. 2006;3:28–36.

    CAS  PubMed  Google Scholar 

  106. Miner M, Esposito K, Guay A, Montorsi P, Goldstein I. Cardiometabolic risk and female sexual health: the Princeton III Summary (CME). J Sex Med. 2012;9(3):641–51.

    PubMed  Google Scholar 

  107. Klein R, Bar-on E, Klein J, Benbenishty R. The impact of sexual therapy on patients after cardiac events participating in a cardiac rehabilitation program. Eur J Cardiovasc Prev Rehabil. 2007;14(5):672–8.

    PubMed  Google Scholar 

  108. Larsen KK, Agerbo E, Christensen B, Søndergaard J, Vestergaard M. Myocardial Infarction and risk of suicide: a population-based case-control study. Circulation. 2010;122:2388–93.

    PubMed  Google Scholar 

  109. Prochaska J, Johnson S, Lee P. The transtheoretical model of behavior change. In: Shumaker SA, Ockene JK, Riekert KA, editors. The handbook of health behavior change. New York: Springer; 2009. pp. 59–83.

    Google Scholar 

  110. Miller WR, Rollnick S. Motivational interviewing: helping people change. 3rd ed. New York: Guilford Press; 2012.

    Google Scholar 

  111. Rollnick S, Miller WR. Butler CC. Motivational interviewing in health care. New York: Guilford Press; 2008.

    Google Scholar 

  112. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71(5):843–61.

    PubMed  Google Scholar 

  113. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55(513):305–12.

    PubMed Central  PubMed  Google Scholar 

  114. Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005;112:924–34.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey L. Goodie Ph.D.ABPP CDR USPHS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Goodie, J., Prentice, P., Larkin, K. (2014). Cardiovascular Disease. In: Hunter, C., Hunter, C., Kessler, R. (eds) Handbook of Clinical Psychology in Medical Settings. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09817-3_19

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-09817-3_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-09815-9

  • Online ISBN: 978-0-387-09817-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics